Table 4.
In vitro cytotoxicity (GI50, μM) of compounds 24a and 29a on four human cell cancer lines.
| Compd. | Family | TRPM8 IC50 (μM) | Lung-NSCLC | Colon | Breast | Pancreas |
|---|---|---|---|---|---|---|
| A549 | HT29 | MDA-MB-231 | PSN1 | |||
| 24a | β-Lactam | 2.4 ± 1.2 | 3.29 | 4.16 | > 17.3 | 5.55 |
| 29a | β-Lactam | 0.4 ± 1.5 | 5.90 | 7.11 | 12.7 | 6.42 |
| 13ab | 2-KP | 17,9 ± 1.3 | > 17.8 | > 17.8 | > 17.8 | > 17.8 |
| 15ab | 2-KP | 1.8 ± 1.9 | > 17.8 | > 17.8 | > 17.8 | 6.4 |
| 30ab | 2-KP | 0.16 ± 1.6 | 12.7 | > 17.3 | > 17.3 | 8.3 |
| Doxorubicin.HCl | − | 0.24 | 0.19 | 0.17 | 0.17 |